Skip to main content

Respiration, Artificial

0
Pipeline Programs
4
Companies
5
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Martin Pharmaceuticals
3 programs
COVID-19N/A1 trial
Characteristics of Weaning From Mechanical Ventilation in COVID-19N/A1 trial
high vs low tidal volumeN/A1 trial
Active Trials
NCT04819165Completed252Est. Jan 2021
NCT05049200Completed326Est. Oct 2020
NCT06195475Completed2,607Est. Oct 2024
Liberate Medical
Liberate MedicalKY - Crestwood
1 program
Breath synchronized abdominal FESN/A1 trial
Active Trials
NCT05759013Enrolling By Invitation272Est. Mar 2026
Medtronic
MedtronicNJ - Phillipsburg
1 program
Proportional Assist VentilationN/A1 trial
Active Trials
NCT00790725Terminated12Est. May 2010
UNION therapeutics
UNION therapeuticsDenmark - Hellerup
1 program
Sedation with CiprofolN/A

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Liberate MedicalBreath synchronized abdominal FES
Martin Pharmaceuticalshigh vs low tidal volume
Martin PharmaceuticalsCharacteristics of Weaning From Mechanical Ventilation in COVID-19
Martin PharmaceuticalsCOVID-19
MedtronicProportional Assist Ventilation

Clinical Trials (5)

Total enrollment: 3,469 patients across 5 trials

NCT05759013Liberate MedicalBreath synchronized abdominal FES

Pivotal Evaluation of Abdominal Neuromuscular Electrical Stimulation (VentFree) for Weaning From Mechanical Ventilation

Start: Feb 2024Est. completion: Mar 2026272 patients
N/AEnrolling By Invitation
NCT06195475Martin Pharmaceuticalshigh vs low tidal volume

Association Between Tidal Volume and Mortality in Pressure Support in Adults Under Invasive Mechanical Ventilation

Start: Nov 2023Est. completion: Oct 20242,607 patients
N/ACompleted
NCT05049200Martin PharmaceuticalsCharacteristics of Weaning From Mechanical Ventilation in COVID-19

Characteristics of Weaning From Mechanical Ventilation in COVID-19

Start: Apr 2020Est. completion: Oct 2020326 patients
N/ACompleted
NCT04819165Martin PharmaceuticalsCOVID-19

Healthcare-associated Infections in Severe COVID-19 During 2020

Start: Mar 2020Est. completion: Jan 2021252 patients
N/ACompleted
NCT00790725MedtronicProportional Assist Ventilation

Proportional Assist Ventilation vs Pressure Support Ventilation

Start: Nov 2008Est. completion: May 201012 patients
N/ATerminated

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.